Canonically, breast carcinomas are grouped as luminal (luminal A and B), HER2 positive, and triple negative subtypes based on the status of estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor receptor 2 (HER2). Here, PGR is linked to breast carcinoma.